Concepedia

Svetlana Markova

SM

Statistics

Publications

16

Citations

768

H-Index

13

Active since

2006

Affiliations

University of California, San Francisco(Current)

Kobe University

Kobe University Hospital

Helsinki University Hospital

Tartu University Hospital

Svetlana Markova is an author at University of California, San Francisco specializing in life sciences, medicine, and pharmacology.

ORCID

Publications per year

2006–2020

16

Publications

16

A Small Molecule Inhibitor of Sarcomere Contractility Acutely Relieves Left Ventricular Outflow Tract Obstruction in Feline Hypertrophic Cardiomyopathy

Joshua A. Stern, Svetlana Markova, Yu Ueda et al. · PLoS ONE · 2016 · 128 citations · Full text

, , +13

Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis

Sergio Borgia, Janet Dearden, Eric M. Yoshida et al. · Journal of Hepatology · 2019 · 123 citations · Full text

, , +15

<i>In vitro</i>and<i>in vivo</i>pharmacokinetic characterization of mavacamten, a first-in-class small molecule allosteric modulator of beta cardiac myosin

Mark P. Grillo, John C. L. Erve, Ryan A. Dick et al. · Xenobiotica · 2018 · 104 citations · Full text

, , +17

Th1/Th17 Plasticity Is a Marker of Advanced β Cell Autoimmunity and Impaired Glucose Tolerance in Humans

Linnea Reinert‐Hartwall, Jarno Honkanen, Harri M. Salo et al. · The Journal of Immunology · 2014 · 75 citations · Full text

, , +17

Attenuation of Cisplatin-Induced Renal Injury by Inhibition of Soluble Epoxide Hydrolase Involves Nuclear Factor κB Signaling

Yingmei Liu, Heather K. Webb, Hisayo Fukushima et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 59 citations · Full text

, , +17

1–5 of 16